Paper32014459
Twist-1 is upregulated by NSD2 and contributes to tumour dissemination and an epithelial-mesenchymal transition-like gene expression signature in t(4;14)-positive multiple myeloma.
Cheong CM and 9 others. Cancer Lett, 2020. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. Twist-1 is upregulated by NSD2 and contributes to tumour dissemination and an epithelial-mesenchymal transition-like gene expression signature in t(4;14)-positive multiple myeloma. Papers, record 32014459. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32014459
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Twist-1 is upregulated by NSD2 and contributes to tumour dissemination and an epithelial-mesenchymal transition-like gene expression signature in t(4;14)-positive multiple myeloma.
- PubMed
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Epithelial-Mesenchymal Transition | Major topic |
| Histone-Lysine N-Methyltransferase | Major topic |
| Multiple Myeloma | Major topic |
| Nuclear Proteins | Major topic |
| Repressor Proteins | Major topic |
| Translocation, Genetic | Major topic |
| Twist-Related Protein 1 | Major topic |
| Animals | |
| Apoptosis | |
| Cell Proliferation | |
| Chromosomes, Human, Pair 14 | |
| Chromosomes, Human, Pair 4 | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Mice | |
| Mice, Inbred C57BL | |
| Prognosis | |
| Transcriptional Activation | |
| Transcriptome | |
| Tumor Cells, Cultured | |
| Xenograft Model Antitumor Assays |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA195732 | NCI NIH HHS | United States | R01CA195732 | PubMed and NIH |
Source NIH RePORTER
References81
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24619707 | TWIST1 expression in breast cancer cells facilitates bone metastasis formation. | J Bone Miner Res | 2014 | https://conductscience.org/library/papers/24619707 | PubMed |
| 2 | 15313894 | Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sézary syndrome identified by gene expression analysis. | Cancer Res | 2004 | https://conductscience.org/library/papers/15313894 | PubMed |
| 3 | 14724576 | Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells. | Oncogene | 2004 | https://conductscience.org/library/papers/14724576 | PubMed |
| 4 | 16728703 | The molecular classification of multiple myeloma. | Blood | 2006 | https://conductscience.org/library/papers/16728703 | PubMed |
| 5 | 16322226 | Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. | Cancer Res | 2005 | https://conductscience.org/library/papers/16322226 | PubMed |
| 6 | 26771021 | The Molecular Signatures Database (MSigDB) hallmark gene set collection. | Cell Syst | 2015 | https://conductscience.org/library/papers/26771021 | PubMed |
| 7 | 21430775 | Initial genome sequencing and analysis of multiple myeloma. | Nature | 2011 | https://conductscience.org/library/papers/21430775 | PubMed |
| 8 | 20678237 | Comparison study of microarray meta-analysis methods. | BMC Bioinformatics | 2010 | https://conductscience.org/library/papers/20678237 | PubMed |
| 9 | 12941819 | SERPINE2 (protease nexin I) promotes extracellular matrix production and local invasion of pancreatic tumors in vivo. | Cancer Res | 2003 | https://conductscience.org/library/papers/12941819 | PubMed |
| 10 | 18326524 | Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics. | Haematologica | 2008 | https://conductscience.org/library/papers/18326524 | PubMed |
| 11 | 20884712 | Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma. | Haematologica | 2011 | https://conductscience.org/library/papers/20884712 | PubMed |
| 12 | 25637218 | Tetraspanin 7 (TSPAN7) expression is upregulated in multiple myeloma patients and inhibits myeloma tumour development in vivo. | Exp Cell Res | 2015 | https://conductscience.org/library/papers/25637218 | PubMed |
| 13 | 25868800 | A review of current murine models of multiple myeloma used to assess the efficacy of therapeutic agents on tumour growth and bone disease. | Bone | 2015 | https://conductscience.org/library/papers/25868800 | PubMed |
| 14 | 9136941 | Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage. | Br J Haematol | 1997 | https://conductscience.org/library/papers/9136941 | PubMed |
| 15 | 11920212 | The 5TMM series: a useful in vivo mouse model of human multiple myeloma. | Hematol J | 2000 | https://conductscience.org/library/papers/11920212 | PubMed |
| 16 | 26445238 | PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma. | J Hematol Oncol | 2015 | https://conductscience.org/library/papers/26445238 | PubMed |
| 17 | 27693633 | Hypoxia induces TWIST-activated epithelial-mesenchymal transition and proliferation of pancreatic cancer cells in vitro and in nude mice. | Cancer Lett | 2016 | https://conductscience.org/library/papers/27693633 | PubMed |
| 18 | 17171682 | Molecular characterization of human multiple myeloma cell lines by integrative genomics: insights into the biology of the disease. | Genes Chromosomes Cancer | 2007 | https://conductscience.org/library/papers/17171682 | PubMed |
| 19 | 25984534 | Extramedullary manifestation in multiple myeloma bears high incidence of poor cytogenetic aberration and novel agents resistance. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/25984534 | PubMed |
| 20 | 24150986 | TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target. | Cancer | 2014 | https://conductscience.org/library/papers/24150986 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42449712 | Overcoming Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma (HNSCC): The Role of Histone Methyltransferase and Demethylase Inhibitors. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42449712 | PubMed |
| 41991312 | [Clinical characteristics and prognosis analysis of newly diagnosed multiple myeloma with t (4;14)]. | Zhonghua Xue Ye Xue Za Zhi | 2026 | https://conductscience.org/library/papers/41991312 | PubMed |
| 41301842 | NSD Family-Mediated H3K36 Methylation in Human Cancer: Mechanisms and Therapeutic Opportunities. | Biomedicines | 2025 | https://conductscience.org/library/papers/41301842 | PubMed |
| 39941895 | Exploring the Role of Epithelial-Mesenchymal Transcriptional Factors Involved in Hematological Malignancy and Solid Tumors: A Systematic Review. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/39941895 | PubMed |
| 39736693 | Disrupting USP39 deubiquitinase function impairs the survival and migration of multiple myeloma cells through ZEB1 degradation. | J Exp Clin Cancer Res | 2024 | https://conductscience.org/library/papers/39736693 | PubMed |
| 38923875 | Intestinal NSD2 Aggravates Nonalcoholic Steatohepatitis Through Histone Modifications. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38923875 | PubMed |
| 38431306 | RAB22A as a predictor of exosome secretion in the progression and relapse of multiple myeloma. | Aging (Albany NY) | 2024 | https://conductscience.org/library/papers/38431306 | PubMed |
| 37699574 | Myeloperoxidase creates a permissive microenvironmental niche for the progression of multiple myeloma. | Br J Haematol | 2023 | https://conductscience.org/library/papers/37699574 | PubMed |
| 37600794 | An "unexpected" role for EMT transcription factors in hematological development and malignancy. | Front Immunol | 2023 | https://conductscience.org/library/papers/37600794 | PubMed |
| 37578463 | Drug Discovery Targeting Nuclear Receptor Binding SET Domain Protein 2 (NSD2). | J Med Chem | 2023 | https://conductscience.org/library/papers/37578463 | PubMed |
| 35999218 | Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35999218 | PubMed |
| 35349390 | Circular RNA PLCE1 promotes epithelial mesenchymal transformation, glycolysis in colorectal cancer and M2 polarization of tumor-associated macrophages. | Bioengineered | 2022 | https://conductscience.org/library/papers/35349390 | PubMed |
| 35203300 | Epithelial Mesenchymal Transition (EMT) and Associated Invasive Adhesions in Solid and Haematological Tumours. | Cells | 2022 | https://conductscience.org/library/papers/35203300 | PubMed |
| 33742125 | NSD2 promotes tumor angiogenesis through methylating and activating STAT3 protein. | Oncogene | 2021 | https://conductscience.org/library/papers/33742125 | PubMed |
| 33626351 | Chromatin dysregulation associated with NSD1 mutation in head and neck squamous cell carcinoma. | Cell Rep | 2021 | https://conductscience.org/library/papers/33626351 | PubMed |
| 33291672 | Tumour Dissemination in Multiple Myeloma Disease Progression and Relapse: A Potential Therapeutic Target in High-Risk Myeloma. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33291672 | PubMed |
| 33147936 | Expression of the chemokine receptor CCR1 promotes the dissemination of multiple myeloma plasma cells in vivo | Haematologica | 2021 | https://conductscience.org/library/papers/33147936 | PubMed |
| 32923989 | Characterization of the role of Samsn1 loss in multiple myeloma development. | FASEB Bioadv | 2020 | https://conductscience.org/library/papers/32923989 | PubMed |
| 32764971 | The Role of Methyltransferase NSD2 as a Potential Oncogene in Human Solid Tumors. | Onco Targets Ther | 2020 | https://conductscience.org/library/papers/32764971 | PubMed |
| 32503307 | Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32503307 | PubMed |
Genes35
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32014459
GET https://conductscience.org/api/papers/v1/32014459/references?page=2